|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 39.78 USD | +4.82% |
|
+6.32% | +45.66% |
| 30/06 | Celldex Therapeutics, Inc.(NasdaqCM:CLDX) added to Russell Small Cap Comp Growth Benchmark | CI |
| 30/06 | Celldex Therapeutics, Inc.(NasdaqCM:CLDX) added to Russell 2500 Growth Benchmark | CI |
| Market Cap | 297.88Cr 260.67Cr 240.24Cr 222.67Cr 422.7Cr 28TCr 429.51Cr 2.88TCr 1.12TCr 14TCr 1.12TCr 1.09TCr 48TCr | P/E 2026 * |
-8.75x | P/E 2027 * | -8.69x |
|---|---|---|---|---|---|
| Enterprise Value | 239.47Cr 209.56Cr 193.13Cr 179.01Cr 339.81Cr 23TCr 345.29Cr 2.32TCr 900.56Cr 11TCr 899.03Cr 879.56Cr 39TCr | EV / Sales 2026 * |
909x | EV / Sales 2027 * | 207x |
| Free-Float |
99.73% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Celldex Therapeutics, Inc.
| 1 day | +4.89% | ||
| 1 week | +6.32% | ||
| Current month | +6.32% | ||
| 1 month | +38.52% | ||
| 3 months | +26.19% | ||
| 6 months | +42.51% | ||
| Current year | +45.66% |
| 1 week | 36.18 |  | 39.76 |
| 1 month | 28.38 | | 39.76 |
| Current year | 22.33 | | 39.76 |
| 1 year | 19.72 | | 39.76 |
| 3 years | 14.4 | | 53.18 |
| 5 years | 14.4 | | 57.2 |
| 10 years | 1.5 | | 75.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
Tibor Keler
CTO | Chief Tech/Sci/R&D Officer | 67 | 30/07/2014 |
Anthony Marucci
CEO | Chief Executive Officer | 64 | 01/09/2008 |
Sam Martin
DFI | Director of Finance/CFO | 55 | 01/04/2009 |
| Director | Title | Age | Since |
|---|---|---|---|
Anthony Marucci
BRD | Director/Board Member | 64 | 01/12/2008 |
Harry Penner
CHM | Chairman | 80 | 05/06/2025 |
Herbert Conrad
BRD | Director/Board Member | 93 | 01/03/2008 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 25/06 | Free | Chief Financial Officer | 93,000 | 0.1185% | ||
| 25/06 | Free | Director | 26,000 | 0.0331% | ||
| 25/06 | Free | Director | 26,000 | 0.0331% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +4.82% | +6.32% | +88.56% | +11.06% | 297.88Cr | |
| -1.03% | +5.24% | +2.94% | +9.41% | 5.03TCr | |
| +1.23% | +2.36% | +422.77% | +626.41% | 4.04TCr | |
| +1.26% | +7.85% | +28.28% | -3.88% | 3.44TCr | |
| -0.63% | +7.73% | +27.40% | +61.97% | 3.44TCr | |
| +1.31% | -0.56% | +5.12% | +33.90% | 2.63TCr | |
| +1.05% | +1.40% | - | - | 1.66TCr | |
| -2.68% | +4.13% | +72.93% | +134.14% | 1.61TCr | |
| +0.32% | +0.53% | +14.33% | +21.47% | 1.37TCr | |
| +3.46% | +8.78% | +106.44% | +106.44% | 1.37TCr | |
| Average | +0.93% | +3.41% | +85.42% | +111.21% | 2.49TCr | |
| Weighted average by Cap. | +0.43% | +4.07% | +96.31% | +140.41% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 26.35L 23.06L 21.25L 19.7L 37.39L 25Cr 37.99L 2.55Cr 99.08L 12Cr 98.92L 96.77L 43Cr | 1.2Cr 1.05Cr 96.48L 89.42L 1.7Cr 113.53Cr 1.72Cr 12Cr 4.5Cr 56Cr 4.49Cr 4.39Cr 193.67Cr |
| Net income | -33Cr -29Cr -27Cr -25Cr -47Cr -3.13TCr -48Cr -319.18Cr -124.13Cr -1.55TCr -123.91Cr -121.23Cr -5.34TCr | -37Cr -32Cr -30Cr -28Cr -53Cr -3.52TCr -53Cr -358.28Cr -139.33Cr -1.74TCr -139.09Cr -136.08Cr -6TCr |
| Net Debt | -58Cr -51Cr -47Cr -44Cr -83Cr -5.54TCr -84Cr -564.87Cr -219.67Cr -2.74TCr -219.29Cr -214.54Cr -9.46TCr | -51Cr -44Cr -41Cr -38Cr -72Cr -4.82TCr -73Cr -490.67Cr -190.81Cr -2.38TCr -190.49Cr -186.36Cr -8.21TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 07/26/07 | $39.44 | +3.93% | 6,45,246 |
| 06/26/06 | $37.95 | -1.09% | 4,70,283 |
| 02/26/02 | $38.37 | +4.32% | 8,76,831 |
| 01/26/01 | $36.78 | -1.16% | 6,79,564 |
| 30/26/30 | $37.21 | -0.61% | 24,73,018 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CLDX Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
